This is not the most recent version of the article. View current version (16 JUL 2013)

Intervention Review

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

  1. Carlo J van Dongen1,*,
  2. Melvin R Mac Gillavry2,
  3. Martin H Prins3

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 14 MAY 2005

DOI: 10.1002/14651858.CD003074.pub2


How to Cite

van Dongen CJ, Mac Gillavry MR, Prins MH. Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003074. DOI: 10.1002/14651858.CD003074.pub2.

Author Information

  1. 1

    Academic Medical Center, University of Amsterdam, Department of Clinical Epidemiology and Biostatistics, Room J2-204, 1100 DE Amsterdam, Netherlands

  2. 2

    Slotervaart Hospital, Department of Internal Medicine, 1066 ED Amsterdam, Netherlands

  3. 3

    University of Maastricht, Department of Epidemiology, Maastricht, Netherlands

*Carlo J van Dongen, Department of Clinical Epidemiology and Biostatistics, Room J2-204, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, Netherlands. c.j.vandongen@amc.uva.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

This is not the most recent version of the article. View current version (16 JUL 2013)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Taki Galanis, Geno J. Merli, Contemporary Treatment of Venous Thromboembolic Disease, Cardiology Clinics, 2015, 33, 1, 49

    CrossRef

  2. 2
    U.O. Gustafsson, M.J. Scott, W. Schwenk, N. Demartines, D. Roulin, N. Francis, C.E. McNaught, J. MacFie, A.S. Liberman, M. Soop, A. Hill, R.H. Kennedy, D.N. Lobo, K. Fearon, O. Ljungqvist, Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations, Clinical Nutrition, 2012, 31, 6, 783

    CrossRef

  3. 3
    Claire MCLINTOCK, Tim BRIGHTON, Sanjeev CHUNILAL, Gus DEKKER, Nolan MCDONNELL, Simon MCRAE, Peter MULLER, Huyen TRAN, Barry N.J. WALTERS, Laura YOUNG, Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2012, 52, 1
  4. 4
    F. Scotté, J. B. Rey, V. Launay-Vacher, Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads, Supportive Care in Cancer, 2012, 20, 12, 3033

    CrossRef

  5. 5
    Robert C. Pendleton, George M. Rodgers, Russell D. Hull, Established Venous Thromboembolism Therapies: Heparin, Low Molecular Weight Heparins, and Vitamin K Antagonists, with a Discussion of Heparin-Induced Thrombocytopenia, Clinics in Chest Medicine, 2010, 31, 4, 691

    CrossRef

  6. 6
    A. Snchez Rodrguez, M. Snchez Ledesma, I. Cruz Gonzlez, Aspectos actuales y perspectivas de futuro del tratamiento de la enfermedad tromboemb?lica, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2006, 9, 69, 4421

    CrossRef

  7. 7
    Sherab Bhutia, Peng F Wong, Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism, The Cochrane Library,
  8. 8
    Pedro Garcia, Wilson Ruiz, Cesar Loza Munarriz, Warfarin initiation nomograms for venous thromboembolism, The Cochrane Library,
  9. 9
    Pedro Garcia, Wilson Ruiz, Cesar Loza Munarriz, Warfarin initiation nomograms for venous thromboembolism, The Cochrane Library,